The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
103871087 10387108 7 F 20140805 20160628 20140815 20160707 EXP PK-ROCHE-1447681 ROCHE 38.00 YR F Y 0.00000 20160707 MD PK PK

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
103871087 10387108 1 PS Pertuzumab PERTUZUMAB 1 Intravenous (not otherwise specified) LOADING DOSE 110723,1117807,1148504 125409 840 MG /cycle
103871087 10387108 2 SS Pertuzumab PERTUZUMAB 1 Intravenous (not otherwise specified) LAST DOSE PRIOR TO SAE 31/MAR/2015?LAST DOSE PRIOR TO SECOND EPISODE OF SEVERE CELLULITUIS ON RIGHT 110723,1117807,1148504 125409 420 MG Q3W
103871087 10387108 3 SS Trastuzumab TRASTUZUMAB 1 Intravenous (not otherwise specified) N3609B03P1,N3752B02 103792 8 MG/KG /cycle
103871087 10387108 4 SS Trastuzumab TRASTUZUMAB 1 Intravenous (not otherwise specified) LAST DOSER PRIOR TO SAE 31/MAR/2015?DOSE: 6MG/KG?LAST DOSE PRIOR TO SECOND EPISODE OF SEVERE CELLULI N3609B03P1,N3752B02 103792 390 MG Q3W
103871087 10387108 5 SS PACLITAXEL. PACLITAXEL 1 Intravenous (not otherwise specified) 0 290 MG
103871087 10387108 6 SS PACLITAXEL. PACLITAXEL 1 Intravenous (not otherwise specified) LAST DOSE PRIOR TO SAE: 09/JUL/2014 0 175 MG
103871087 10387108 7 C ONDANSETRON ONDANSETRON 1 Unknown 0 8 MG
103871087 10387108 8 C ONDANSETRON ONDANSETRON 1 Unknown 0 8 MG
103871087 10387108 9 C TRAMADOL. TRAMADOL 1 Unknown 0 50 MG
103871087 10387108 10 C LISINOPRIL. LISINOPRIL 1 Unknown 0 10 MG
103871087 10387108 11 C RANITIDINE. RANITIDINE 1 Unknown 0 50 MG
103871087 10387108 12 C DEXAMETHASONE. DEXAMETHASONE 1 Unknown 0 4 MG
103871087 10387108 13 C CHLORPHENIRAMINE. CHLORPHENIRAMINE 1 Unknown 0 10 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
103871087 10387108 1 HER-2 positive breast cancer
103871087 10387108 3 HER-2 positive breast cancer
103871087 10387108 5 HER-2 positive breast cancer

Outcome of event

Event ID CASEID OUTC COD
103871087 10387108 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
103871087 10387108 Cellulitis
103871087 10387108 Pneumonia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
103871087 10387108 1 20140505 20140505 0
103871087 10387108 2 20140708 0
103871087 10387108 3 20140504 0
103871087 10387108 4 20140709 0
103871087 10387108 5 20140504 0
103871087 10387108 6 20140709 0
103871087 10387108 7 20140505 0
103871087 10387108 8 20140708 20140713 0
103871087 10387108 9 20140923 20140930 0
103871087 10387108 10 20140923 0
103871087 10387108 11 20140505 0
103871087 10387108 12 20140505 0
103871087 10387108 13 20140505 0